Campaign Against Woodcock’s US FDA Commissioner Bid Has Begun
Executive Summary
Opioid issues delayed Robert Califf’s confirmation as FDA commissioner. Could they prevent the nomination of Janet Woodcock?
You may also be interested in...
Trove Of Opioid Documents May Help Shape Public Health Policy
As sponsors and US FDA continue to face fallout, newly launched digital archive of industry documents from opioid litigation and settlements will be free public resource for those investigating activities that led to the opioid epidemic. It is modeled on the archive of tobacco industry documents, which has been the basis of about 1,000 scientific publications.
White House Reiterates Confidence In FDA Expertise, Independence With J&J Vaccine Pause
Not only did White House and other officials support the recommendation, but also made clear they had no advance notice of it.
Cavazzoni Helms US FDA Drug Center With OTC Monograph Reform Starting, Novel Switches Next
Patrizia Cavazzoni, who likely represents a somewhat different leadership style for CDER, distinguished herself while leading the center temporarily during the COVID-19 pandemic.